Gentian Diagnostics ASA (OSL:GENT)

Norway flag Norway · Delayed Price · Currency is NOK
60.60
-0.40 (-0.66%)
Jun 24, 2025, 11:31 AM CET
44.29%
Market Cap 940.76M
Revenue (ttm) 158.07M
Net Income (ttm) 48.89M
Shares Out 15.42M
EPS (ttm) 3.08
PE Ratio 19.81
Forward PE 37.85
Dividend 0.40 (0.66%)
Ex-Dividend Date May 7, 2025
Volume 81
Average Volume 36,043
Open 60.20
Previous Close 61.00
Day's Range 60.20 - 60.60
52-Week Range 37.00 - 63.00
Beta 0.35
RSI 56.33
Earnings Date Jul 10, 2025

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 63
Stock Exchange Oslo Børs
Ticker Symbol GENT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.